Abstract
Eosinophil-related cardiovascular toxicity mostly consists of endomyocardial fibrosis, endocardial thrombi (with subsequent potential cardiac embolism), venous thromboembolism, and eosinophilic vasculitis.1,2 Eosinophilia-related coronary vasospasm is a rare and underrecognized life-threatening condition that has been reported in patients with aspirin-exacerbated respiratory disease (AERD), eosinophilia-myalgia syndrome, hypereosinophilic syndrome (HES), and eosinophilic granulomatosis with polyangiitis (EGPA).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of Allergy and Clinical Immunology: In Practice
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
